Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Royal Bank of Canada (TSX:RY)

287.23 -1.89 (-0.65%)
Streaming Delayed Price Updated: 1:38 PM EDT, Jun 26, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Royal Bank of Canada

< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
News headline image
The #1 Stock I’d Keep Forever Inside a TFSA ↗
A renewable energy powerhouse with visible business growth potential is an ideal lifelong investment for a TFSA. 
Via The Motley Fool
Topics Artificial Intelligence Retirement
News headline image
Lattice Semiconductor (LSCC) Shares Skyrocket, What You Need To Know
What Happened? Shares of semiconductor designer Lattice Semiconductor (NASDAQ:LSCC) jumped 9.7% in the afternoon session after CEO Ford Tamer's presentation ... 
Via StockStory
Topics Artificial Intelligence Government
News headline image
Beam Therapeutics Eyes Sickle Cell BLA as Alpha-1 Gene-Editing Program Advances ↗
Beam Therapeutics (NASDAQ:BEAM) Chief Executive Officer John Evans said the company is advancing its base-editing platform across hematology and liver disease programs, with a potential biologics... 
Via MarketBeat
Topics Intellectual Property
News headline image
Why Are GE Aerospace (GE) Shares Soaring Today
What Happened? Shares of industrial conglomerate GE Aerospace (NYSE:GE) jumped 5% in the afternoon session after the company secured a U.S. Air Force contrac... 
Via StockStory
Topics Bonds Economy
RBC Bearings Inc (NYSE:RBC) Shares Rise After Q4 Earnings Beat Driven by Aerospace & Defense Surge ↗
Via Chartmill
Topics Earnings
News headline image
2 Canadian Stocks Primed to Surge in 2026 ↗
Two Canadian stocks with powerful fundamental catalysts are poised to deliver exceptional gains in 2026. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Arrowhead Pharmaceuticals Eyes Q3 SHASTA Data as REDEMPLO Approvals Build Momentum ↗
Arrowhead Pharmaceuticals (NASDAQ:ARWR) executives said the company is entering a key period marked by new regulatory approvals, early commercial progress for REDEMPLO and upcoming Phase 3 data in... 
Via MarketBeat
News headline image
Are Wall Street Analysts Predicting Church & Dwight Stock Will Climb or Sink?
Church & Dwight has underperformed the broader market over the past year, but analysts are cautiously optimistic about the stock’s prospects. 
Via Barchart.com
Topics ETFs
News headline image
Agios Pharmaceuticals Touts Strong AQVESME Launch as Sickle Cell Filing Advances ↗
Agios Pharmaceuticals (NASDAQ:AGIO) executives said the company is focused on advancing mitapivat across rare hematologic diseases, highlighting early launch traction in thalassemia and a recently... 
Via MarketBeat
News headline image
ACADIA Pharmaceuticals Spotlights Alzheimer’s Psychosis Pipeline, NUPLAZID and DAYBUE Growth ↗
ACADIA Pharmaceuticals (NASDAQ:ACAD) executives used an RBC Capital Markets investor session to outline the company’s clinical rationale for remlifanserin in Alzheimer’s disease psychosis, provide... 
Via MarketBeat
News headline image
Addus HomeCare Says License Moratorium Won’t Slow Personal Care Growth, M&A ↗
Addus HomeCare (NASDAQ:ADUS) executives said a new federal moratorium on certain home health licenses should have little effect on the company’s growth plans, while highlighting continued improvement... 
Via MarketBeat
News headline image
The Top 3 Canadian ETFs I’m Considering for 2026 ↗
The top three Canadian ETFs are reliable passive monthly income providers to investors seeking instant diversification. 
Via The Motley Fool
Topics Artificial Intelligence ETFs
News headline image
3 TSX Stocks Built for Higher-for-Longer Interest Rates ↗
Three TSX stocks are strong buys if a higher-for-longer interest rate environment is forthcoming. 
Via The Motley Fool
Topics Artificial Intelligence Economy
News headline image
Regeneron Sinks 10% on Failed Phase 3 Melanoma Trial. What Comes Next for REGN Stock.
Regeneron stock sinks as fianlimab Phase 3 trial fails to meet primary endpoint. But RBC continues to see significant upside in REGN shares from here. 
Via Barchart.com
News headline image
Do Wall Street Analysts Like Thermo Fisher Scientific Stock?
While Thermo Fisher Scientific has considerably underperformed the broader market over the past 52 weeks, Wall Street analysts maintain a highly optimistic outlook about the stock’s prospects. 
Via Barchart.com
Topics ETFs
News headline image
A 6.4% Dividend Stock Paying Out Monthly ↗
A high-yield stock operating within a specialized niche in the real estate sector pays monthly dividends. 
Via The Motley Fool
Topics Artificial Intelligence Retirement
News headline image
RBC Q1 Deep Dive: Aerospace and Defense Momentum Drives Revenue Growth, Margin Outlook Stable
Bearings manufacturer RBC Bearings (NYSE:RBC) beat Wall Street’s revenue expectations in Q1 CY2026, with sales up 18.3% year on year to $518 million. Guidanc... 
Via StockStory
Topics Economy
News headline image
The Best Dividend Stocks to Buy and Hold Forever ↗
Canadians can form a lasting, self-sustaining income engine with the best dividend stocks. 
Via The Motley Fool
Topics Artificial Intelligence Energy
News headline image
Here’s the Average TFSA and RRSP at Age 45 ↗
The average TFSA and RRSP at age 45 is far from ideal but Canadians in their mid-life have ample time to secure their financial futures. 
Via The Motley Fool
Topics Artificial Intelligence Bonds Retirement
News headline image
Why Repligen (RGEN) Stock Is Trading Up Today
What Happened? Shares of biopharma manufacturing company Repligen Corporation (NASDAQ:RGEN) jumped 2.9% in the afternoon session after RBC Capital resumed co... 
Via StockStory
Topics Artificial Intelligence Economy
News headline image
Crude Oil Surges 3%; RBC Bearings Earnings Top Views ↗
US stocks down, S&P 500 falls 1%; Dow down 1.08%, NASDAQ down 1.42%. Energy shares up 1.5%; materials stocks down 2.1%. RBC Bearings beats Q1 estimates. 
Via Benzinga
Topics Stocks
News headline image
RBC (RBC) Q4 2026 Earnings Call Transcript ↗
RBC (RBC) Q4 2026 Earnings Call Transcript 
Via The Motley Fool
Topics Earnings
News headline image
RBC Bearings Q4 Earnings Call Highlights ↗
RBC Bearings (NYSE:RBC) reported a record fiscal fourth quarter for 2026, with management pointing to strong aerospace and defense demand, steady industrial growth and continued debt reduction as key... 
Via MarketBeat
Topics Earnings
News headline image
RBC Bearings Reports Q4 2026 Results: Full Earnings Call Transcript ↗
 
Via Benzinga
Topics Earnings
News headline image
3 TSX Stocks Built to Earn, Pay, and Endure ↗
Three TSX stocks are compelling options for risk-averse investors prioritizing dividend safety and reliability over high yields. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Danaher Stock: Analyst Estimates & Ratings
Danaher has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects. 
Via Barchart.com
Topics ETFs
News headline image
RBC Bearings (NYSE:RBC) Beats Q1 CY2026 Sales Expectations
Bearings manufacturer RBC Bearings (NYSE:RBC) reported Q1 CY2026 results exceeding the market’s revenue expectations, with sales up 18.3% year on year to $51... 
Via StockStory
News headline image
RBC Bearings Likely To Report Higher Q4 Earnings; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call ↗
RBC Bearings (NYSE: RBC) will release its Q4 earnings on May 15. Analysts expect earnings of $3.32/share and revenue of $506.59 million. 
Via Benzinga
News headline image
RBC Bearings, Applied Materials And 3 Stocks To Watch Heading Into Friday ↗
US stock futures down, key stocks to watch: RBC Bearings, Applied Materials, Surgepays, Nu Holdings & Figma. Figma reports strong Q1 results. 
Via Benzinga
News headline image
Analysts Say Applied Materials Is Built For The AI Chip Supercycle ↗
AMAT hits $440 as Wall Street raises targets. Citi, Lynx, and RBC lift Applied Materials forecasts up to $550 on AI chip boom. 
Via Benzinga
Topics Artificial Intelligence
< Previous 1 2 3 4 5 6 7 8 9
...
47 48 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.